The choice of drugs for treatment of allergic rhinitis depends on the severity of symptoms and whether they are are intermittent or persistent (see Table 1).1
H1-ANTIHISTAMINES — Oral second-generation H1-antihistamines (see Table 2) are recommended for initial treatment of intermittent allergic rhinitis symptoms (nasal itching, sneezing, and rhinorrhea). They can also reduce ocular symptoms (itching, tearing, redness).1
Oral first-generation...
- An EUA for Bamlanivimab and Etesevimab for COVID-19
- Oriahnn for Fibroid-Associated Heavy Menstrual Bleeding
- Semaglutide (Ozempic) for Weight Loss
- Low-Dose Colchicine for Coronary Artery Disease
- In Brief: Hypertension with Erenumab (Aimovig)
- Ripretinib (Qinlock) for GIST (online only)
- COVID-19 Vaccine Comparison Chart (online only)
RELEASE
The oral fixed-dose combination of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker (ARB) valsartan (Entresto – Novartis) was approved by the FDA in 2015 to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction (HFrEF; LVEF <40%).
